Covetrus Inc. (CVET) News
Filter CVET News Items
CVET News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CVET News Highlights
- CVET's 30 day story count now stands at 2.
- Over the past 17 days, the trend for CVET's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- BEN and TPG are the most mentioned tickers in articles about CVET.
Latest CVET News From Around the Web
Below are the latest news stories about COVETRUS INC that investors may wish to consider to help them evaluate CVET as an investment opportunity.
Westlake Set to Join S&P MidCap 400; MillerKnoll to Join S&P SmallCap 600Westlake Corp. (NYSE:WLK) will replace MillerKnoll Inc. (NASD:MLKN) in the S&P MidCap 400, and MillerKnoll will replace Covetrus Inc. (NASD:CVET) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 18. Clayton, Dubilier & Rice and TPG Capital acquired Covetrus in a deal that closed today. MillerKnoll is more representative of the small-cap market space. |
Covetrus Names Michelle Bonfilio as Chief People OfficerPORTLAND, Maine, September 26, 2022--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer, reporting to Ben Wolin, President and Chief Executive Officer at Covetrus. In this role, Bonfilio will oversee the human resources and communications organizations and help shape the culture of the company. |
Moody's assigns B2 CFR to Covetrus, Inc.; Outlook StableThe ratings are being assigned in conjunction with a leveraged buyout of the company. Moody's also assigned B1 ratings to the company's proposed first-lien credit facilities, consisting of a $300 million bank revolving credit facility expiring 2027, and a $1,525 million term loan due 2029. |
Covetrus Names Margie B. Pritchard General CounselPORTLAND, Maine, August 26, 2022--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Margie B. Pritchard as General Counsel and Corporate Secretary, reporting to Ben Wolin, President and Chief Executive Officer (CEO) at Covetrus. |
Covetrus Announces Retirement of Matthew FoulstonPORTLAND, Maine, August 11, 2022--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that Matthew Foulston, the Company’s Executive Vice President and Chief Financial Officer, has informed the company that he will be retiring from the company effective December 31, 2022. |
Covetrus (CVET) Q2 Earnings Match EstimatesCovetrus (CVET) delivered earnings and revenue surprises of 0% and 1.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock? |
Covetrus Announces Financial Results for Second Quarter of 2022PORTLAND, Maine, August 04, 2022--Covetrus Announces Financial Results for Second Quarter of 2022 |
Covetrus Announces Second Quarter 2022 Earnings Release DatePORTLAND, Maine, July 28, 2022--Covetrus will release second quarter 2022 results before the markets open on Thursday, August 4, 2022. |
Study Reveals New Covetrus Technology Saves Time, Provides Relief to Overworked, Understaffed Veterinary PracticesPORTLAND, Maine, July 26, 2022--Animal health and technology services company, Covetrus, announces a new customer survey finding Covetrus Pulse saves time and is easy to implement. |
CD&R, TPG Take Covetrus Private In $4B DealClayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ: CVET) for $21.00 per share, representing an enterprise value of approximately $4 billion. CD&R and its affiliates currently beneficially own approximately 24% of the company's outstanding shares of common stock. The transaction represents a 39% premium to Covetrus' 30-day volume-weighted average price per share as of the unaffected stock pri |